Genesystem Co (XKRX:363250) Additional Paid-In Capital : ₩0.0 Mil(As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Additional Paid-In Capital?

Genesystem Co's quarterly additional paid-in capital increased from Sep. 2023 (₩11,606.5 Mil) to Dec. 2023 (₩11,746.1 Mil) but then stayed the same from Dec. 2023 (₩11,746.1 Mil) to Mar. 2024 (₩0.0 Mil).

Genesystem Co's annual additional paid-in capital increased from Dec. 2021 (₩52,080.2 Mil) to Dec. 2022 (₩52,382.6 Mil) but then declined from Dec. 2022 (₩52,382.6 Mil) to Dec. 2023 (₩11,746.1 Mil).

Genesystem Co Additional Paid-In Capital Historical Data

The historical data trend for Genesystem Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Additional Paid-In Capital Chart

Genesystem Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

81.40

24,847.52

52,080.15

52,382.59

11,746.11

Genesystem Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial											11,419.56	11,606.70	11,606.45	11,746.11	-

Genesystem Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Genesystem Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Genesystem Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Genesystem Co (XKRX:363250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028

Website

http://www.genesystem.co.kr

Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines